新型烈性犬保定器械的研制与应用

保定的目的是要控制烈性犬的攻击性行为,从而保证人的安全。而保定器械在使用过程中也不能损伤到犬本身,要在其使用过程中尽量减少犬的应激。保定器械应具备实用性,即材质要牢靠、大小要适中、使用要方便,重复使用时犬接受保定的成功率要高。最后,还应考虑到是否便于消毒、所占场地大小等一系列相关问题。     

新型烈性犬保定器械的研制与应用

如何有效的控制烈性犬在预防免疫、检查与治疗过程中的攻击性行为,历来是宠物门诊中的难题.理想的保定器械应具备安全、牢靠、使用简便、便于消毒、不损伤犬本身、多次重复使用时犬接受率高、能够得到犬主人的认可等一系列优点.     

犬的八种器械保定法

<正>对于陌生的犬,或性格暴烈的犬,特别是藏獒等进行检查或诊治时,防止意外伤人,采用一些简单的物品进行保定非常实用。现根据笔者从事畜牧兽医工作50多年,将用过的八种保定方法简介如下,供同行们在实际工作中参考选用。(1)棉制绷带保定法:用绷带或布条打一个活结或猪蹄扣,套在犬鼻梁部和中部,结在下颌下,将绷带两端自下颌处分别向后上方引至背部打结,将犬的口固定住,使犬不能张口,此法适用于口鼻较长的犬。     

犬的几种常用器械保定法

在对藏獒等性格暴烈的犬进行检查或诊治时,为防止犬意外伤人,采用一些简单的物品进行保定非常实用。现根据笔者长期从事畜牧兽医工作的经验,将用过的几种常用保定方法简介如下。     

犬的保定方法

犬的保定方法甘肃省畜牧学校王治仓随着人们生活水平的提高，伴侣犬逐渐进入家庭。犬从牧羊、护卫、狩猎、军用到伴侣动物，其地位日益提高。伴随着养犬业的发展，犬病日益增多，影响犬的健康甚至危害人类，因此对犬病应及时诊疗。但病犬骚动不安，甚至抓伤或咬伤诊疗人员...     

犬的保定与防护

1犬的接近犬对主人有较强的依恋性,陌生人接近犬时,最好有主人在场。首先向犬发出接近信号（如呼唤犬的名字或发出温和的呼声,以引起犬的注意）,然后从犬前方徐徐绕至其前侧视线内,一面观察其反应,一面接近。单眼瞎的犬从健侧接近,接近双眼瞎的犬时应特别小心。     

犬猫保定技术与注意事项

犬、猫在诊疗时,可能会咬伤或抓伤医疗人员,或由于骚动而影响治疗操作。因此,应给予适当的保定。犬、猫对主人有较强的依恋性,所以保定时最好由主人共同参与操作。尤其是犬、猫,当由主人抱在胸前更有利于检查和治疗。犬、猫保定的方法很多,有以语言、人力、器械、药物等方法控制犬、猫,限制其防卫活动,确保人和犬猫的安全。     

犬的简易保定法

笔者经过多年的实践 ,自制了一种适用于犬戴的铁丝“笼头” ,很好地解决了犬的保定问题。经过 40多个场 (户 ) 6 80多条犬的实际应用 ,收到了很好的效果 ,现将此法介绍如下。笼头的制作与使用 :取直径 1ｍｍ、长约 1ｍ的细铁丝 1根 ,将两头交叉在铁丝的中部挽成一个与犬嘴大小相符的圆圈。再从交叉处开始 ,2段铁丝各向相反方向缠绕 1/4周 ,起加固笼头圈的作用。剩余铁丝每段约长 2 0ｃｍ为宜 ,作为笼头的 2条系带。使用时 ,饲养人员边抚摸犬头边将笼头圈套在犬嘴巴上。然后拉住 2条系带 ,从两耳后上升到脑顶 ,在枕脊前打结。注意事项 :笼头…     

常用的犬保定方法

一、简易保定 （一）扎口保定 本法适用于一般检查或简单处置。训养的犬可让犬主蹲于犬的右侧,右手将犬头抱于胸前,左手臂抱紧犬的后躯加以固定;未经训服的犬,先用捕犬钳夹紧颈部,另一人则用粗扁带绕上下颌一周,在上颌上打一结,然后转向下颌,再作一结,最后将带牵引至头后颈背上打第三个结,此结应为活结。也可用口笼套嘴,然后作进一步保定。     

常用的犬保定方法

一、简易保定 （一）扎口保定 本法适用于一般检查或简单处置。训养的犬可让犬主蹲于犬的右侧,右手将犬头抱于胸前,左手臂抱紧犬的后躯加以固定;未经训服的犬,先用捕犬钳夹紧颈部,另一人则用粗扁带绕上下颌一周,在上颌上打一结,然后转向下颌,再作一结,最后将带牵引至头后颈背上打第三个结,此结应为活结。也可用口笼套嘴,然后作进一步保定。     

犬Ⅱ型腺病毒蚀斑技术的建立和初步应用

犬Ⅱ型腺病毒(CAV-2)是犬喉气管炎的病原,通常只引起轻微的呼吸道疾病[1],但是在其它病毒或细菌继发感染的情况下可诱发较严重的肺炎、支气管炎、扁桃体炎[2],直接影响我国军、警犬和实验犬的培育、训练和使用.本文拟建立一个广泛适用的犬腺病毒蚀斑技术,为进一步以犬腺病毒为载体的重组弱病毒疫苗的筛选提供一个有效的技术方法.介绍如下.     

犬细小病毒新2b型分离株的分离鉴定

为了更好的了解我国东北地区犬细小病毒的流行情况,采用F81细胞从来自长春某宠物医院疑似患有肠炎的犬粪便样品中分离出1株病毒,经形态学、血清学、动物回归试验和分子生物学鉴定,分离的病毒为犬细小病毒new CPV-2b型,命名为CPV JL13-1。对该病毒主要结构蛋白VP2基因进行克隆测序和基因进化分析表明,CPV JL13-1分离株VP2基因与GenBank上提交的其他41株犬细小病毒株核苷酸和氨基酸均有较高的同源性,分别为98.6%~99.5%和97.6%~99.5%,其中核苷酸和氨基酸同源性最高的均为B-2004株。本研究为犬细小病毒分子流行病学调查和疫苗的研究奠定基础。     

犬脱卸式活动围栏设计与临床应用效果观察

为了解决宠物门诊中的烈性犬保定问题,以Φ6′镀锌自来水管为主要材料设计、焊制脱卸式活动围栏,并在临床实践中不断改进和观察应用效果。结果表明,该围栏对于各种体格的烈性犬均具有可靠的保定效果,对人和犬均十分安全,而且操作简单,容易清洗和消毒。     

A new storage medium for canine blood

A solution consisting of ascorbate phosphate, citric acid, sodium citrate, sodium phosphate, and dextrose was developed to extend the shelf life of canine blood stored for transfusion. The 24-hour poststorage viability remained above 70% for 6 weeks of storage at 4 C. The concentration of 2,3 diphosphoglycerate remained constant for 3 weeks, then declined slowly. After 6 weeks of storage, the 2,3 diphosphoglycerate content was still sufficiently high to allow adequate dissociation of oxygen from oxyhemoglobin in vivo. It was concluded that blood stored up to 6 weeks in this solution would be safe to use for transfusion.     

新型的食品和饲料添加剂--茶多酚的研究与应用

本文简述了生理活性物质茶多酚的理化特性与生物学活性；剖析了茶多酚的作用机理；阐述了茶多酚的研究与应用进展；并展望了茶多酚在食品和饲料工业及畜牧业中的应用前景。     

The palliative efficacy of modified Mohs paste for controlling canine and feline malignant skin wounds

In veterinary medicine, the management of malignant skin wounds is highly challenging. We conducted a study on seven case animals (four dogs and three cats) which presented with malignant skin wounds. All seven animals had signs and symptoms which were controlled following treatment with a modified Mohs paste. Upon obtaining informed consent from their owners, the animals requiring management of malignant wounds were enrolled in this study. The modified Mohs paste was prepared by mixing zinc chloride, zinc oxide starch powder, glycerin, and distilled water. The modified Mohs paste was topically applied to and left to remain on the malignant wounds for one hour, under controlled conditions. Once the paste was removed, the wounds were irrigated with a solution of sterile saline. At the first examination, the wounds of each animal were observed for signs of exudate, malodor, and bleeding. In every case, visible improvement was observed immediately after the modified Mohs paste treatment. Specifically, the size of the malignant wounds, and the number of times the dressing gauze required changing, significantly decreased (p < 0.05 and p < 0.01, respectively). The open malignant skin wounds caused by mammary gland tumors disappeared in two cases. The Mohs paste has been shown to be a viable option for the palliative treatment in canine and feline malignant skin wound management.     

Evaluation of a new treatment for canine scabies and demodicosis

A total of forty-eight dogs were utilized to titrate and evaluate the activity of a new miticide, amitraz. The treatment was applied dermally and evaluated for efficacy against experimentally induced Demodex canis and Sarcoptes scabiei infestations. Five different concentrations (2000, 1000, 500, 250, 125 p.p.m.) of the active drug, N'—(2, 4-dimethylphenyl)N—{[(2, 4-dimethylphenyl) imino] methyl} -N-methyl-methanimidamide, were tested. The activity of amitraz was compared to a standard treatment, placebo treatment, and no treatment.
A single dermal treatment with amitraz (all concentrations) indicated activity against both D. canis and S. scabiei. The lowest concentration of active drug (125 p.p.m.) was significantly less efficacious than the four higher concentrations (250, 500, 1000, 2000 p.p.m.). At the 250 p.p.m. (or higher) level the effectiveness of this new miticide was comparable to the standard treatment. The data indicate the 250 p.p.m. concentration is the optimal level and the recommended dilution for treatment of mange mites. Drug reactions related to amitraz were not observed.     

Three-year serologic immunity against canine parvovirus type 2 and canine adenovirus type 2 in dogs vaccinated with a canine combination vaccine

A group of client-owned dogs and a group of dogs at a commercial kennel were evaluated for duration of antibody responses against canine parvovirus type 2 (CPV-2) and canine adenovirus type 1 (CAV-1) after receiving a combination vaccine containing recombinant canarypox-vectored canine distemper virus (CDV) and modified-live CPV-2, CAV-2, and canine parainfluenza virus, with (C6) or without (C4) two serovars of Leptospira (Recombitek C4 or C6, Merial). Duration of antibody, which correlates with protective immunity, was found to be at least 36 months in both groups. Recombitek combination vaccines can confidently be given every 3 years with assurance of protection in immunocompetent dogs against CPV-2 and CAV-1 as well as CDV. This allows this combination vaccine, like other, similar modified- live virus combination products containing CDV, CAV-2, and CPV-2, to be administered in accordance with the recommendations of the American Animal Hospital Association Canine Vaccine Task Force.